Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian J Hobbs

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
British Journal of Pharmacology|June 28, 2002
Soluble guanylate cyclase: an old therapeutic target re-visitedAdrian J Hobbs
American Journal of Physiology. Heart and Circulatory Physiology|May 21, 2016
Guanylyl cyclase can't stand the HETEAdrian J Hobbs
Circulation Research|July 9, 2016
A Janus-Faced Role for Atrial Natriuretic Peptide in Myocardial Infarction?Adrian J Hobbs
Trends in Pharmacological Sciences|March 8, 2005
Endothelium-derived C-type natriuretic peptide: more than just a hyperpolarizing factorAmrita Ahluwalia, Adrian J Hobbs
Circulation|January 16, 2013
Letter by Ahluwalia and Hobbs regarding article, "Nitrate-nitrite-nitric oxide pathway in pulmonary arterial hypertension therapeutics"Amrita Ahluwalia, Adrian J Hobbs
Vascular Pharmacology|September 19, 2003
Antiplatelet properties of a novel, non-NO-based soluble guanylate cyclase activator, BAY 41-2272Adrian J Hobbs, Salvador Moncada
Handbook of Experimental Pharmacology|December 18, 2008
NO-independent, haem-dependent soluble guanylate cyclase stimulatorsJohannes-Peter Stasch, Adrian J Hobbs
Nitric Oxide : Biology and Chemistry|November 30, 2020
A comparison of the chemical biology of hydropersulfides (RSSH) with other protective biological antioxidants and nucleophilesJon M Fukuto, Adrian J Hobbs
Vascular Pharmacology|November 12, 2015
The nuances of NO synthase regulation in sepsis: Could targeting BH4 be the answer?Claire A Sand, Adrian J Hobbs
International Journal of Molecular Sciences|May 11, 2019
C-type Natriuretic Peptide: A Multifaceted Paracrine Regulator in the Heart and VasculatureAmie J Moyes, Adrian J Hobbs
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
British Journal of Pharmacology|June 28, 2002
Soluble guanylate cyclase: an old therapeutic target re-visitedAdrian J Hobbs
American Journal of Physiology. Heart and Circulatory Physiology|May 21, 2016
Guanylyl cyclase can't stand the HETEAdrian J Hobbs
Circulation Research|July 9, 2016
A Janus-Faced Role for Atrial Natriuretic Peptide in Myocardial Infarction?Adrian J Hobbs
Trends in Pharmacological Sciences|March 8, 2005
Endothelium-derived C-type natriuretic peptide: more than just a hyperpolarizing factorAmrita Ahluwalia, Adrian J Hobbs
Circulation|January 16, 2013
Letter by Ahluwalia and Hobbs regarding article, "Nitrate-nitrite-nitric oxide pathway in pulmonary arterial hypertension therapeutics"Amrita Ahluwalia, Adrian J Hobbs
Vascular Pharmacology|September 19, 2003
Antiplatelet properties of a novel, non-NO-based soluble guanylate cyclase activator, BAY 41-2272Adrian J Hobbs, Salvador Moncada
Handbook of Experimental Pharmacology|December 18, 2008
NO-independent, haem-dependent soluble guanylate cyclase stimulatorsJohannes-Peter Stasch, Adrian J Hobbs
Nitric Oxide : Biology and Chemistry|November 30, 2020
A comparison of the chemical biology of hydropersulfides (RSSH) with other protective biological antioxidants and nucleophilesJon M Fukuto, Adrian J Hobbs
Vascular Pharmacology|November 12, 2015
The nuances of NO synthase regulation in sepsis: Could targeting BH4 be the answer?Claire A Sand, Adrian J Hobbs
International Journal of Molecular Sciences|May 11, 2019
C-type Natriuretic Peptide: A Multifaceted Paracrine Regulator in the Heart and VasculatureAmie J Moyes, Adrian J Hobbs
Pageof 10